Aesthetic medicine products. Shiseido announces candidates for Directors and Audit & Supervisory Board Members

Derma filler

THE WHAT Shiseido has announced the candidates for the Directors and Audit & Supervisory Board Members to replace exiting External Director Yoshiaki Fujimori. 

THE DETAILS Voting will take place at the company’s 122nd Ordinary General Meeting of Shareholders, which will be held in late March 2022. 

If approved, the new External Directors will be Charles D. Late II and Mariko Tokuno. 

Fat dissolving

Directors and Audit & Supervisory Board Members will include Masahiko Uotani, Yukari Suzuki, Norio Tadakawa, and Takayuki Yokota, amongst others. 

Audit & Supervisory Board Members will include Takeshi Yoshida and Akiko Uno.

According to Shiseido, as Takeshi Yoshida’s term will expire at the end of the General Meeting of Shareholders, the company will propose him as a candidate for reappointment as Audit & Supervisory Board Member at the General Meeting of Shareholders.

THE WHY The new appointments follow the retirement of External Director Yoshiaki Fujimori, which will take place after the GM. 

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.

  Aesthetic medicine products. DHC Corp to exit South Korean market following discriminatory row